← Leaderboards
Djuro Josic
Rhode Island Hospital
$3,979,733
Attributed
$3,979,733
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–11$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$3,979,733 · 6
By mechanism
P20$3,480,031 · 5
S10$499,702 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Proteomics”
- David Heimbrook · Leidos Biomedical Research, Inc.$318,825,229
- Stanley M Lemon · Univ Of North Carolina Chapel Hill$110,612,005
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Gaetano T Montelione · Rutgers The St Univ Of Nj New Brunswick$70,176,616
- Rolf Apweiler · European Molecular Biology Laboratory$67,677,991
- Daniel Ernest Ford · Johns Hopkins University$67,257,868
Research focus
ProteomicsNci Center For Cancer ResearchFundingProteinsResearch And DevelopmentMass Spectrum AnalysisBioinformaticsServicesHospitalsGenomeInstrumentationCenters Of Research ExcellenceResourcesRhode IslandSamplingResearch PersonnelChromatographyProgramsGrantInstitutionPeptidesComplexLongevityElectrophoresis
Grant awards (7)
COBRE: RIH: CORE B: PROTEOMICS: PROTEIN BIOINFORMATICS, HU GENOME, DNA$570,199
P20 · FY2011 · RR · contact PI
COBRE: RIH: CORE B: PROTEOMICS: PROTEIN BIOINFORMATICS, HU GENOME, DNA$530,328
P20 · FY2010 · RR · contact PI
COBRE: RIH: CORE B: PROTEOMICS: PROTEIN BIOINFORMATICS, HU GENOME, DNA$614,495
P20 · FY2009 · RR · contact PI
Ultraspec III TOF/TOF 200 MALDI-TOF Mass Spectrometry Imaging System$499,702
S10 · FY2009 · RR · contact PI
COBRE: RIH: CORE B: PROTEOMICS: PROTEIN BIOINFORMATICS, HU GENOME, DNA$525,698
P20 · FY2006 · RR · contact PI
COBRE: RIH: CORE B: PROTEOMICS: PROTEIN BIOINFORMATICS, HU GENOME, DNA$576,738
P20 · FY2005 · RR
COBRE: RIH: CORE--PROTEOMICS: PROTEIN BIOINFORMATICS,$662,573
P20 · FY2004 · RR